Drugs and Devices

FDA approves new drug for Gaucher disease

On August 19, the U.S. Food and Drug Administration (FDA) approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, which affects about 6,000 people in the United States. Read more.

Related Articles:

Leave a Reply

You have to agree to the comment policy.